American Society of Addiction Medicine
American Society of Addiction Medicine
Lead Story: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020
Lead Story: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020
Lead Story: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020
Tuesday 26th July 2022
Explore CDC findings on overdose deaths and racial disparities during the pandemic in ASAM's 'Addiction Medicine Unpacked' podcast.
7 minutes
Informative
Thought-provoking
Raw
Engaging
Educational
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
172 (View all)
Do you want to link to this podcast?
Get the buttons here!Pandemic Overdose Deaths: A Deep Dive into Racial Disparities and Treatment Gaps
During the pandemic, racial disparities in overdose deaths widened, increasing by [percentage] from [year] to [year] and with rates that spiked higher among black and American, Indian and Alaskan native populations.
What happens when a pandemic collides with an ongoing drug overdose crisis? In this episode of 'Addiction Medicine Unpacked', the host Claire Rasmussen sheds light on the CDC's latest report, which paints a grim picture of escalating overdose deaths and widening racial disparities. From 2019 to 2020, overdose deaths surged by 30%, but the spike was even more pronounced among Black, American Indian, and Alaska Native communities compared to other groups.
This troubling trend continued into 2021, with over 107,000 deaths recorded, primarily driven by illicit fentanyl. The episode doesn't just stop at the statistics; it digs into the human stories behind the numbers. Most of those who died had no history of treatment for substance use disorder, with white individuals having slightly better access to treatment than other racial and ethnic groups. The episode also explores related studies on antidepressants, alcohol consumption, smoking, and methadone treatment outcomes.
One key takeaway is the urgent need for universal screening for mood disorders among opioid users. The host also discusses the potential mechanisms behind alcohol-related cognitive decline and the causal links between smoking and multiple diseases. Buprenorphine's favorable outcomes for pregnant women compared to methadone are also highlighted.
If you're interested in understanding how these issues intersect with public health and social justice, this episode offers a comprehensive and engaging look at some of the most pressing challenges in addiction medicine today.